Originally published by our sister publication Pain Medicine News
The FDA has approved over-the-counter (OTC) naloxone hydrochloride (HCI) nasal spray, USP, 4 mg (Amneal Pharmaceuticals), following an abbreviated new drug application review. Naloxone HCI Nasal Spray is a generic equivalent to OTC Narcan HCI Nasal Spray (Emergent), a medication that is widely used to help treat drug overdose from opioids, including heroin, fentanyl and prescription opioid medications.
Naloxone HCI